Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
      • Research Guidelines
        • Minimum Information About Microarray Data Experiments (MIAME)
      • Abstract
      • Acknowledgments
      • Clinical Implications (Only by invitation)
      • Conflict(s) of Interest/Disclosure(s) Statement
      • Figure Legends
      • Figures
      • Novelty and Significance: 1) What Is New, 2) What Is Relevant?
      • References
      • Sources of Funding
      • Tables
      • Text
      • Title Page
      • Online/Data Supplement
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
      • Change of Authorship Form
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Hypertension

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Hypertension Electronic Pages

Letter: Antioxidant Activities and Oxidative Stress Byproducts in Human Hypertension

Madhu Khullar, Vandana Relan, B.S. Sherawat
Download PDF
https://doi.org/10.1161/01.HYP.0000111210.34843.b6
Hypertension. 2004;43:e7-e8
Originally published January 29, 2004
Madhu Khullar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vandana Relan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B.S. Sherawat
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • References
    • References
  • Info & Metrics
  • eLetters
Loading

To the Editor:

We note with interest the study by Redon et al1 on antioxidant activities and oxidative stress byproducts in human hypertension. The authors have reported an increase in oxidative stress and a reduction in the activity of antioxidant mechanisms in hypertensive subjects which appeared to be independent of the blood pressure levels. Although oxidative stress is known to occur in hypertension, direct cause-and-effect relationships have not been clearly delineated. Several factors inherent to hypertensive status such as enhanced activity of angiotensin II, hyperinsulinemia, and increased NAD(P)H oxidase activity have been implicated in inducing altered oxidative state in hypertension. Oxidative stress has been seen to promote the entry of Ca2+ into vascular myocytes, stimulating neointimal hyperplasia and vasoconstriction.2 Although no relationship between oxidative stress and blood pressure values was observed by Redon et al,1 such a relationship cannot be excluded. In fact, we have observed a significant negative correlation between diastolic blood pressure and several endogenous antioxidants in hypertensive patients. We found a negative correlation between glutathione-S-transferase (GST; r=−0.52), glutathione peroxidase (GPx; r=−0.46), ascorbic acid (r=−0.40), and non-protein thiols (r=−0.482). The levels of GST, GPx, ascorbic acid, and non-protein thiols were observed to be significantly low in hypertensives as compared with normotensives. We also observed a significant decrease in plasma ferric-reducing antioxidant power (FRAP) in hypertensives as compared to normotensive controls, which also showed a negative correlation (r=−0.52) with diastolic pressure. FRAP is a direct indicator of antioxidant status and measures endogenous reduction of Fe+3 to Fe+2. A low FRAP activity would lead to increased Fe+3, which is a potent pro-oxidant and would result in increased oxidative stress. The increased oxidative stress observed in hypertensive patients could lead to endothelial dysfunction by increasing intracellular Ca levels. Antioxidants such as probucol and ascorbic acid have been shown to improve endothelium-dependent relaxation, suggesting the role of reactive oxygen species (ROS) in endothelial dysfunction. Redon et al1 have also proposed that ROS products released from peripheral mononuclear cells may also contribute to endothelial dysfunction and organ damage present in hypertensive subjects. We have observed significantly lower nitric oxide levels in hypertensive patients. There was, however, no correlation between severity of disease, organ damage, and plasma nitric oxide levels. Patients on antihypertensive therapy (Ca channel blockers or ACE inhibitors) showed a significant increase in nitric oxide levels, but their antioxidant levels remained lower as compared with normotensives. Thus, there appear to be other factors contributing to oxidative stress, which need to be further investigated.

References

  1. 1.↵
    Redon J, Olivia MR, Tormos C, Giner V, Chaves J, Iradi A, Saez GT. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension. 2003; 41: 1096–1101.
    OpenUrlAbstract/FREE Full Text
  2. 1.↵
    Dhalla NS, Temsah RM, Netticadam T. Oxidative stress and cardiovascular diseases. J Hypertens. 2000; 18: 655–663.
    OpenUrlCrossRefPubMed

Response




Letters to the Editor will be published, if suitable, as space permits. They should not exceed 1000 words (typed double-spaced) in length and may be subject to editing or abridgment.

Khullar et al1 commented in their study that hypertensive subjects had a reduced activity in plasma of the antioxidant systems, glutathione-S-transferase, glutathione peroxidase, ascorbic acid, non-protein thiols, and the plasma ferric-reducing antioxidant power as compared with normotensive controls. Furthermore, a lower nitric oxide activity was also present in hypertensive subjects compared with the normotensive control group. These data correspond to the findings of our group measuring the activity of other antioxidant enzymes, SOD, catalase, and glutathione peroxidase2 in plasma and in mononuclear cells. How the results of Khulla et al differ from our own data are in the finding of a significant negative correlation between the antioxidant activity and the diastolic blood pressure, a correlation that was not present in our own data. The authors, however, did not provide information about the number of subjects analyzed, selection criteria, or characteristics of the study population, making it difficult to discuss more in depth what the explanation for the different results could be. In our study, patients were analyzed out of antihypertensive treatment, and 85% of them were previously untreated. Furthermore, blood pressure was assessed using 24-hour ambulatory BP monitoring, a more accurate estimate of BP. More detailed information is required to find out whether differences in the selection criteria and/or characteristics of the hypertensive subjects analyzed would be able to explain the discrepancies.

Another commentary addressed by the authors is that the antihypertensive treatment produced a significant increase in nitric oxide levels, but the antioxidant levels remained lower as compared with normotensive subjects. The authors did not explain whether antihypertensive treatment had induced an increase in antioxidant mechanisms even when they did not achieve the values observed in normotensive subjects. In our experience, antihypertensive treatment reduces oxidative stress parameters and increases the activity of the antioxidant enzymes, in both plasma and mononuclear cells. A complete normalization of these values was observed after 1 year of treatment.

The relationship among the production of reactive oxygen species and their control, BP values, and hypertension-induced organ damage is a complex phenomenon. More studies are necessary to understand further the significance of oxidative stress in hypertension.

References

  1. 1.↵
    Khullar M, Relan V, Sherawat BS. Antioxidant activities and oxidative stress byproducts in human hypertension.Hypertension. 2003;in press.
  2. 1.↵
    Redon J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A, Saez GT. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension. 2003; 41: 1096–1101.
    OpenUrlAbstract/FREE Full Text
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Hypertension
February 2004, Volume 43, Issue 2
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • References
    • References
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Letter: Antioxidant Activities and Oxidative Stress Byproducts in Human Hypertension
    Madhu Khullar, Vandana Relan and B.S. Sherawat
    Hypertension. 2004;43:e7-e8, originally published January 29, 2004
    https://doi.org/10.1161/01.HYP.0000111210.34843.b6

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Hypertension.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Letter: Antioxidant Activities and Oxidative Stress Byproducts in Human Hypertension
    (Your Name) has sent you a message from Hypertension
    (Your Name) thought you would like to see the Hypertension web site.
  • Share on Social Media
    Letter: Antioxidant Activities and Oxidative Stress Byproducts in Human Hypertension
    Madhu Khullar, Vandana Relan and B.S. Sherawat
    Hypertension. 2004;43:e7-e8, originally published January 29, 2004
    https://doi.org/10.1161/01.HYP.0000111210.34843.b6
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Hypertension

  • About Hypertension
  • Instructions for Authors
  • AHA CME
  • Guidelines and Statements
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
7272 Greenville Ave.
Dallas, TX 75231
email: hypertension@heart.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured